Ketcher 11141912032D 1 1.00000 0.00000 0 27 29 0 0 0 999 V2000 13.0888 -11.7109 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0 14.8209 -14.7109 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 11.3568 -14.7109 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 12.2228 -17.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.2228 -19.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.3568 -21.7109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.6379 -17.5199 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.6379 -15.9018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 -15.7109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 -18.7109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.6869 -16.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.6869 -17.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9549 -16.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8209 -15.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9549 -17.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8209 -17.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 -17.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.2258 -16.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 -14.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2228 -14.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9549 -14.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.9470 -18.4710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2228 -13.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 -12.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.9549 -13.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2228 -20.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3568 -20.7109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 24 1 0 0 0 14 2 1 0 0 0 20 3 1 0 0 0 17 4 2 0 0 0 10 5 1 0 0 0 5 26 1 0 0 0 27 6 1 0 0 0 7 12 1 0 0 0 18 7 1 0 0 0 7 22 1 0 0 0 11 8 1 0 0 0 8 18 2 0 0 0 9 13 1 0 0 0 19 9 1 0 0 0 17 10 1 0 0 0 12 11 1 0 0 0 11 14 2 0 0 0 16 12 2 0 0 0 14 13 1 0 0 0 13 15 2 0 0 0 15 16 1 0 0 0 15 17 1 0 0 0 19 20 1 0 0 0 21 19 2 0 0 0 20 23 2 0 0 0 25 21 1 0 0 0 23 24 1 0 0 0 24 25 2 0 0 0 26 27 1 0 0 0 M END > CHEBI:145371 > binimetinib > A member of the class of benzimidazoles that is 1-methyl-1H-benzimidazole which is substituted at positions 4, 5, and 6 by fluorine, (4-bromo-2-fluorophenyl)nitrilo, and N-(2-hydroxyethoxy)aminocarbonyl groups, respectively. It is a MEK1 and MEK2 inhibitor (IC50= 12 nM). Approved by the FDA for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation in combination with encorafenib. > 3 > NVP-MEK162; N-(2-hydroxyethoxy)-4-fluoro-5-(2-fluoro-4-bromophenylamino)-1-methyl-1H-benzoimidazole-6-carboxamide; MEK162; MEK-162; ARRY-438162; ARRY-162; ARRY 438162; ARRY 162; 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide > 5-(4-bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide > binimetinibum; binimetinib; binimetinib; binimetinib > Mektovi > C17H15BrF2N4O3 > 441.233 > 440.02956 > 0 > BrC=1C=C(F)C(NC=2C(F)=C3N=CN(C3=CC2C(=O)NOCCO)C)=CC1 > InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) > ACWZRVQXLIRSDF-UHFFFAOYSA-N > 606143-89-9 > 606143-89-9 > DB11967 > D10604 > LSM-45640 > Binimetinib > PMC6012544 > 23414587; 27071922; 28152546; 28412197; 28587477; 28851243; 29785570; 29946554; 30117021; 30635233; 30648436; 30652516; 30956763; 31050693; 31129802; 31213500; 31312030; 31395751; 31436845; 31437754; 31631932 $$$$